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Fatty Acid Biosynthesis Inhibition
Increases Reduction Potential in
Neuronal Cells under Hypoxia
Stephen A. Brose, Svetlana A. Golovko and Mikhail Y. Golovko*
Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND, USA
Recently, we have reported a novel neuronal specific pathway for adaptation to hypoxia
through increased fatty acid (FA) biosynthesis followed by esterification into lipids.
However, the biological role of this pathway under hypoxia remains to be elucidated.
In the presented study, we have tested our hypothesis that activation of FA synthesis
maintains reduction potential and reduces lactoacidosis in neuronal cells under hypoxia.
To address this hypothesis, we measured the effect of FA synthesis inhibition on
NADH+/NAD+ and NADPH+/NADP+ ratios, and lactic acid levels in neuronal SH-SY5Y2 2
cells exposed to normoxic and hypoxic conditions. FA synthesis inhibitors, TOFA (inhibits
Acetyl-CoA carboxylase) and cerulenin (inhibits FA synthase), increased NADH+/NAD+2
and NADPH+/NADP+ ratios under hypoxia. Further, FA synthesis inhibition increased2
lactic acid under both normoxic and hypoxic conditions, and caused cytotoxicity under
hypoxia but not normoxia. These results indicate that FA may serve as hydrogen
acceptors under hypoxia, thus supporting oxidation reactions including anaerobic
glycolysis. These findings may help to identify a radically different approach to attenuate
hypoxia related pathophysiology in the nervous system including stroke.
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INTRODUCTION
Despite the significant role for brain hypoxia in the development of many of pathophysiological
conditions including stroke, traumatic brain injury, tumorigenesis, aging, and neurodegenerative
diseases (Gallagher and Hackett, 2004; Wilson et al., 2009; Raymond et al., 2011; Clambey et al.,
2012; Kirby et al., 2012; Lin et al., 2013), biochemical mechanisms for adaptation to hypoxia are
still poorly understood. Recently, we have discovered a previously unknown and neuron-specific
mechanism for utilizing anaerobic metabolism during hypoxia. We have found that hypoxic-
stressed neurons have a unique response of dramatically increased fatty acid (FA) synthesis from
glutamine and glutamate (Gln/Glu) (Brose et al., 2014). However, the biochemical significance of
this pathway in neuronal adaptation to hypoxia is unknown. Previously, we have hypothesized
a few mechanisms to address the importance for activated FA synthesis from Gln/Glu under
hypoxia (Brose et al., 2014) including balancing Glu levels, protection against oxidative stress,
and maintaining reduction potential with support of anaerobic glycolysis. In the present study,
Abbreviations: FA, fatty acids; Gln, glutamine; Glu, glutamate; LDH, lactate dehydrogenase; MS, mass spectrometry; UPLC,
ultra-pressure liquid chromatography.
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we have tested one of these hypotheses that FA SYNTHESIS
supports anaerobicmetabolism under hypoxia through accepting
hydrogen from reduced cofactors (NADH+2 , NADPH
+
2 , FADH2),
thus maintaining reduction potential.
Under hypoxia, hydrogen accumulates on reduced cofactors
(NADH+2 , NADPH
+
2 , FADH2; Garofalo et al., 1988; Obi-
Tabot et al., 1993; Foster et al., 2005), due to the decrease
in O2 as its final acceptor. This results in a decreased
ATP production through oxidative phosphorylation, and an
increased ratio of reduced/oxidized cofactors in the cell and
therefore, an increased reduction potential. The altered reduction
potential has several devastating effects on cells including lactate
accumulation as an alternative H2 acceptor and subsequent
pH drop (Payen et al., 1996; Malisza et al., 1999; Zhang
et al., 2006), increased formation of reactive oxygen species
which damage lipids, proteins, and DNA (Magalhães et al.,
2005), DNA modification through modulation of sirtuin Sirt1
activity (Lin et al., 2004), decreased rates of oxidation reactions
such as glycolysis or Glu/Gln oxidation (McKenna, 2007), and
a further decrease in ATP production (Pettit et al., 1975).
Because FA synthesis consumes two hydrogens from reduced
cofactors for each 2 carbons incorporated, we hypothesize that FA
synthesis may have a role as a hydrogen acceptor from reduced
cofactors under hypoxia, thus maintaining cellular reduction
potential.
To address this hypothesis, we applied a previously validated
in-vitro model for neuronal hypoxia using SH-SY5Y cells
exposed to 19% (normoxia) or 1% (hypoxia) oxygen levels
(Brose et al., 2014). FA synthesis was inhibited at two different
steps in the biosynthetic pathway using tetradecyloxy-2-furoic
acid (TOFA, inhibits Acetyl-CoA carboxylase Loftus et al.,
2000) and cerulenin (inhibits FA synthase, Heiligtag et al.,
2002; Lupu and Menendez, 2006). FA synthesis inhibition
significantly increased NADH+2 /NAD
+ and NADPH+2 /NADP
+
ratios under hypoxia and resulted in increased lactic acid
under both normoxic and hypoxic conditions. Importantly,
FA synthesis inhibition caused cytotoxicity under hypoxia but
not normoxia. These results indicate that FA may serve as
hydrogen acceptors under hypoxia, thus supporting oxidation
reaction including anaerobic glycolysis. These findings may
help to identify a radically different approach to attenuate
hypoxia related pathophysiology in the nervous system including
stroke.
MATERIALS AND METHODS
Materials
SH-SY5Y cells were a gift from Dr. Colin Combs. All culture
media and horse serum were purchased from Life Technologies
(Grand Island, NY, USA). Fetal bovine serum (FBS) was
purchased from Serum Source International (Charlotte, NC,
USA). L-[U 14C] glutamaic acid (260 mCi/mmol) was purchased
from PerkinElmer (Waltham, MA, USA). TOFA and cerulenin
were purchased from Cayman Chemical (Ann Arbor, MI,
USA). All other chemicals and solvents used were purchased
from Fisher Scientific (Waltham, MA USA) and were LC-MS
grade.
Cell Culture and Hypoxic Treatment
Cells were plated 3 days before the experiment on a six-well plate
(Cellstar, Griner Bio-One, Monroe, NC, USA) at a density of
1.5 million cells per well. The cells were grown in Dulbecco’s
modified Eagle medium with nutrient mixture F-12 (DMEM/F-
12) with 10% FBS and 5% horse serum at 37◦C and 5% CO2.
The hypoxic treatment was as described earlier (Brose et al.,
2014). Briefly, the cells were preconditioned by replacing the
growth medium with serum-free minimum essential media
(MEM) and incubating in 19% O2 (Normoxia) or 1% O2
(Hypoxia) in 5% CO2 at 37◦C using nitrogen gas to purge the
oxygen. After 24 h, the media was replaced with 2 mL of fresh
serum-free MEM containing radiolabeled tracer (2 µCi [U-14C
Glu]) and/or fatty acid synthesis inhibitor (TOFA, 2 µg/mL;
cerulenin, 1 µg/mL) and returned to their respective incubation
conditions for another 18 h. A short re-oxygenation during
media change did not significantly affect the FA synthesis rate as
was estimated using de-oxygenated media (data not shown).
Lipid Extraction and Saponification
To measure incorporation of radiotracer into fatty acids, cellular
lipids were extracted and saponified as described earlier (Brose
et al., 2014). Briefly, the media was removed and the cells were
washed twice with ice-cold phosphate buffered saline. After
removing the final wash, 0.5 mL of methanol was added to the
cells; they were scraped and transferred into a silanized with
Sigmacote (Sigma Chemical Co., St. Louis, MO) screw top glass
tube. Another, 0.5 mL of methanol was added, the plates were
scraped again, and the solution was combined with the methanol
solution. A Folch extract (Folch et al., 1957) was performed by
adding an additional 1 mL of methanol and 4 mL chloroform.
The mixture was soniciated using a probe sonicator (Model
150 Sonic Dismembrator, Fisher Scientific) and centrifuged at
2000 × g for 10 min. The supernatant was transferred into a
new silanized screw top glass tube and was washed with 1.2
mL saline (0.9% sodium chloride). The extract was washed an
additional two times with 1.2 mL chloroform:methanol:water
(3:48:47). The extract was dried under nitrogen, re-dissolved in
the saponification solution (180 µL methanol and 20 µl 5M
potassium hydroxide in water) and heated to 60◦C for 60 min
to saponify. The samples were then neutralized with 20 µL 5 M
hydrochloric acid in water. After neutralization, 780 µL of saline
was added and the fatty acids were extracted with 2 mL hexane
three times. The combined hexane extracts were evaporated and
the fatty acids were re-dissolved in 1 mL of hexane. Radioactivity
of an aliquot of the samples was measured in 10 mL Cytoscint
(MP Biomedicals; Solon, OH, USA) using a scintillation counter
(LS-6500, Beckman Coulter, Pasadena, CA, USA).
Cytotoxicity
Cytotoxicity was measured as a percent of lactate dehydrogenase
(LDH) released from the cells into the media using an enzymatic
kit (BioVision, Milpitas, CA, USA). Media was collected, and the
cells were lysed in 1 mL of the included lysis buffer. For both
media and cell lysate, 10 µL was used for LDH measurement.
Absorbance was measured at 450 nm using a Flexstation III plate
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reader (Molecular Devices; Sunnyvale, CA, USA). LDH released
was calculated as (LDHmedium/LDHmedium+cells)×100%.
Lactic Acid
Lactic acid was measured using 20 µL of media with a
fluorescence-based enzymatic kit from Cayman Chemical.
Fluorescence was measured with a Flexstation III plate reader
using an excitation wavelength of 535 nm and an emission
wavelength of 590 nm with a cutoff filter of 570 nm.
NAD+/NADH2 and NADP
+/NADPH2
Measurement
Nucleotides were extracted from cells under ice-cold conditions
by adding ice-cold 0.5 mL methanol:water (80:20) containing
0.1 mg/mL ethylenediaminetetraacetic acid and scraping the
cells. The solution containing cells was transferred to a 1.5 mL
microcentrifuge tube. Another 0.5 mL of the methanol:water
solution was added to each well, the wells were scraped again,
and the wash was combined with the previous wash. The
combined solutions were sonicated, centrifuged at 10000 × g
for 10 min at 4◦C. The supernatant was transferred into a 2
mL microcentrifuge tube and was washed from lipids with 1
mL hexane 2 times. The remaining solution was evaporated in
a vacuum concentrator. The residue was redissolved in 20 µL
water and transferred into a silanizedmicrovial insert (Microsolv,
Eatontown, NJ USA part number 9502S-02ND) and 10 µL was
injected into the LC-MS.
Nucleotides were separated on the same day using a
HYPERCARB column (3 µm, 250 Å, 150 × 2.1 mm; Thermo
Fisher Scientific; Waltham, MA, USA) maintained at room
temperature. The LC system was aWaters AQUITYUPLC pump
and a well plate autosampler (Waters; Milford, MA, USA). The
autosampler temperature was 8◦C. Solvent A consisted of water
containing 2 mM ammonium acetate at pH 10 and solvent B
consisted of acetonitrile containing 2 mM ammonium acetate at
pH 10. The flow rate was 0.3 mL/min and the initial conditions
were 97% A and 3% B. The initial conditions were held for
0.5min. B was increased to 10% over 8 min and held for 2 min. B
was then further increased to 25% over 2 min and held for 4min.
Finally, B was increased to 98% over 4min and held for 7.5 min. B
was then returned to the initial conditions over 0.5 min and held
for 2 min.
Quantification of nucleotides was performed on a Waters
Synapt G2-S quadrupole time-of-flight mass spectrometer
(Q-TOF). The electrospray ionization was in negative ion mode
as previously described (Brose et al., 2013). The cone voltage
was 20 V with a capillary voltage of 1.51 kV. The source
temperature was 110◦C. The desolvation temperature was 350◦C.
The cone gas flow was 10 L/h, the desolvation gas flow was
1000 L/h and the nebulizer gas was 6bar. The analyzer was
operated in the centroid sensitivity mode with an extended
dynamic range with a resolution of 10,000. Mass correction was
performed using leucine enkephalin (400 pg/µL, ACN: water,
50: 50) which was infused at 10 µL/min. The acquisition rate
was 10 hertz. NAD+, NADH+2 , NADP
+, and NADPH+2 were
quantified using m/z 662.1013, 664.1161, 742.0670, and 744.0833
Da, respectively. Instrument control, acquisition, and sample
analysis was performed using MassLynx V4.1 software (Waters).
Statistics
Statistical comparisons were determined using an ANOVA with
Tukey’s post-hoc test. Statistical significance was defined as
<0.05. Values are expressed as mean ± SD. GraphPad Prism
6 (GraphPad; San Diego, CA) software was used for statistical
analysis.
RESULTS
To address the role for increased FA synthesis under hypoxia,
we use our previously validated model for neuronal cell hypoxia
(Brose et al., 2014). Consistent with our previous results, FA
synthesis from Glu was dramatically 6.4-fold increased in SH-
SY5Y cells under 1% O2 (Figure 1). Next, we inhibited FA
synthesis at the Acetyl-CoA carboxylase (TOFA, Loftus et al.,
2000) or FA synthase (cerulenin, Heiligtag et al., 2002; Lupu and
Menendez, 2006) reactions. The inhibitors TOFA and cerulenin
were used at concentrations 5- and 3-fold above their IC50 values,
respectively (Zhu et al., 2004; Wu et al., 2011), and significantly
inhibited FA synthesis from Glu under both normoxic and
hypoxic conditions (Figures 1A,B) while they were not toxic
under normoxia (Figure 1C). Importantly, at the concentrations
used, TOFA demonstrated a higher potency to inhibit FA
synthesis under both normoxia (5.1-fold FA synthesis inhibition
by TOFA compared to 1.7-fold inhibition by cerulenin) and
hypoxia (8.1-fold FA synthesis inhibition by TOFA compared to
2.2-fold inhibition by cerulenin) (Figures 1A,B).
To assay the effect of FA synthesis inhibition on cellular
reduction potential, we applied a high resolution accurate
mass LC-MS approach to measure NADH+2 /NAD
+ and
NADPH+2 /NADP
+ ratios under normoxia and hypoxia
(Figure 2). In the control (vehicle treated) cells, hypoxia
resulted in an increased NADH+2 /NAD
+ ratio in both TOFA
and cerulenin experiments. This is consistent with hypoxic
conditions when O2 levels are insufficient to accept H2 from
reduced cofactors through the electron transport chain. Slight
differences in the NADH+2 /NAD
+ and NADPH+2 /NADP
+
ratios between experiments may be attributed to the differences
between culture age and density because TOFA and cerulenin
experiments were performed at different times, and the
NADH+2 /NAD
+ ratio is closely linked to physiological and
pathological states (Schwartz et al., 1974; Atzori et al., 1990;
Zhang et al., 2006; Sun et al., 2012). Surprisingly, hypoxia
decreased NADPH+2 /NADP
+ ratio. This is consistent with
previous reports (Tribble and Jones, 1990; Gupte and Wolin,
2006; Kathagen-Buhmann et al., 2016) and may be associated
with the depression of pentose-phosphate pathway (Gupte and
Wolin, 2006; Kathagen-Buhmann et al., 2016). Alternatively,
decreased NADPH+2 under hypoxia may be explained through
significant increased FA synthesis that utilizes NADPH+2 as a
cofactor.
Consistent with our hypothesis, both inhibitors significantly
increased both NADH+2 /NAD
+ and NADPH+2 /NADP
+ ratios
under hypoxia as compared to vehicle treated hypoxic cells
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FIGURE 1 | Fatty acid synthesis from glutamate in SH-SY5Y cells was inhibited by TOFA and cerulenin under normoxia (19% O2) and hypoxia (1% O2)
and did not cause toxicity under normoxia. (A,B): SH-SY5Y cells were preconditioned in serum-free MEM for 24 h under normoxia or hypoxia. The media was
replaced with a fresh media and the cells were pretreated with vehicle (control, 1 µL/mL DMSO), (A) TOFA (2 µg/mL), or (B) cerulenin (1 µg/mL) for 30 min. [U-14C]
glutamate (2 µCi) was then added to the wells. The cells were incubated for another 18 h under normoxia or hypoxia. Fatty acid (FA) radioactivity was determined as
described in the Materials and Methods. (C): Percent of LDH released into the media was measured under normoxic (19% O2) conditions to confirm the inhibitors
TOFA (2 µg/mL) and cerulenin (1 µg/mL) were not toxic at the concentrations used. *-significantly different, p < 0.05. Values are mean ± SD, n = 3.
(Figure 2). Similar to the effect on FA synthesis, TOFA
had a stronger effect on NADH+2 /NAD
+ ratios (1.8-fold
increase as compared to vehicle treated hypoxic cells) as
compared to cerulenin (1.3-fold increase), while the effect on
NADPH+2 /NADP
+ ratios was similar for both inhibitors (∼3-
fold increase as compared to vehicle treated hypoxic cells).
Because the NADH+2 /NAD
+ ratio is closely related to
anaerobic glycolysis and lactic acidosis which are both activated
under 1% hypoxia (Zhang et al., 2006), we assayed the effect of FA
synthesis inhibition with TOFA onmedia lactic acid (Figure 3A).
Consistent with anaerobic glycolysis activation under hypoxia,
1% O2 increased media lactic acid 1.9-fold. TOFA did not
have an effect on lactic acid under normoxia, but significantly
increased lactate under hypoxia 2.6-fold as compared to vehicle
treated hypoxic cells (Figure 3A). Consistent with increased
NADH+2 /NAD
+ and NADPH+2 /NADP
+ ratios, and increased
lactoacidosis under hypoxia, TOFA dramatically increased
cytotoxicity under hypoxia but not normoxia as measured by
cellular LDH release (Figure 3B).
DISCUSSION
Despite the significant contribution of brain hypoxia in
the development of many of pathophysiological conditions,
biochemical mechanisms for neuronal adaptation to hypoxia are
still not completely understood. Previously, using both primary
neurons and neuronal cell lines, we have reported a novel
response of neuronal cells to hypoxia through a dramatic increase
in FA synthesis from Gln/Glu (Brose et al., 2014). However, the
biological importance for this pathway has not been addressed.
To explain the role for increased FA synthesis under neuronal
hypoxia, we have previously hypothesized few mechanisms that
may have a complimentary protective role, including balancing
Glu levels, protection against oxidative stress, and maintaining
reduction potential with support of anaerobic glycolysis (Brose
et al., 2014). In the current study, we have addressed the role
for FA synthesis in supporting reduction potential as a potent
acceptor of hydrogen under hypoxia.
The mechanism for alterations in reduction potential under
hypoxia is well understood. Under hypoxia, hydrogen transfer
from substrates to oxygen in the electron transport chain
in mitochondria is decreased. This leads to accumulation
of hydrogen on intermediate cofactors (NADH+2 , NADPH
+
2 ,
FADH2; Garofalo et al., 1988; Obi-Tabot et al., 1993; Foster
et al., 2005). Because the total pool of reduced and oxidized
co-factors is unchanged, the level of oxidized cofactors is
decreased, thus the ratio between reduced and oxidized
cofactors is increased. As a result, ATP levels are decreased,
while the reduced cofactors (NADH+2 , NADPH
+
2 , FADH2)
are significantly increased, limiting energy production and
increasing reduced/oxidized cofactor ratio in cells. In addition,
cells are unable to completely oxidize pyruvate and acetyl-CoA
produced in glycolysis and glutaminolysis (McKenna, 2007).
In line with this mechanism, and consistent with previous
studies when 1% O2 was used to model hypoxia (Zhang et al.,
2006), we observed a significant increase in the NADH+2 /NAD
+
ratio and lactic acid accumulation in control hypoxic cells
(Figures 2, 3). However, similar to previous reports (Tribble and
Jones, 1990; Gupte and Wolin, 2006; Kathagen-Buhmann et al.,
2016), hypoxia decreased the NADPH+2 /NADP
+ ratio (Figure 2)
which may be explained through the depression of the pentose-
phosphate pathway(Gupte andWolin, 2006; Kathagen-Buhmann
et al., 2016). Alternatively, decreased NADPH+2 under hypoxia
may be explained through significantly increased FA synthesis
under hypoxia since FA synthesis utilizes NADPH+2 as a cofactor.
Astrocytes and, to a lesser extent, neurons adapt to hypoxic
conditions through switching to anaerobic glycolysis. However,
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FIGURE 2 | NADH+2 /NAD
+ and NADPH+2 /NADP
+ levels under hypoxia
are increased with fatty acid synthesis inhibition. Inhibition of fatty acid
synthesis in hypoxic SH-SY5Y cells increases the amounts of NADH+2 (A,C)
and NADPH+2 (B,D) relative to their oxidized forms. SH-SY5Y cells were
preconditioned in serum-free MEM for 24 h under normoxia or hypoxia. The
media was switched to a fresh media and the cells were treated with vehicle
(control, 1 µL/mL DMSO), cerulenin (1 µg/mL) (A,B), or TOFA (2 µg/mL) (C,D)
and were incubated for another 18 h under normoxia or hypoxia. Nucleotides
were extracted with 80:20 methanol: water containing EDTA and were
analyzed with LC-MS as described in the Materials and Methods.
*-significantly different, p < 0.05. Values are mean ± SD, n = 3.
under hypoxia anaerobic glycolysis leads to further accumulation
of both reduced cofactors and lactic acid (Figure 3). This is
consistent with attenuation of NADH+2 accumulation under
hypoxia when glucose levels are decreased (Garofalo et al., 1988).
The altered reduction potential has several devastating effects
on cells. It results in: 1. Further lactate accumulation (as an
alternative acceptor of hydrogen), and pH drop (Payen et al.,
1996; Malisza et al., 1999; Zhang et al., 2006). Importantly,
even under normoxia, astrocytic lactate production is very
high to provide this key metabolite to neurons for energy
metabolism (Hu and Wilson, 1997; Galeffi et al., 2007). Under
hypoxia, neuronal oxidative potential is limited, decreasing
lactate utilization; 2. Reactive oxygen species formation with
consequential damage to lipids, proteins, and DNA (Magalhães
et al., 2005). This paradoxical phenomenon of hypoxia-induced
oxidative stress is explained through increased mitochondrial
reductive stress (Turrens et al., 1985; Duranteau et al., 1998).
FIGURE 3 | Inhibition of fatty acid synthesis with TOFA in SH-SY5Y
cells increases lactic acid levels and toxicity under hypoxia. SH-SY5Y
cells were preconditioned in serum-free MEM for 24 h under normoxia or
hypoxia. The media was switched to a fresh media and the cells were treated
with vehicle (control, 1 µL/mL DMSO) or TOFA (2 µg/mL). The cells were
incubated for another 18 h under normoxia or hypoxia. (A): Lactic acid was
measured using an enzymatic fluorescent kit. (B): Toxicity was determined
through percent of LDH release which was measured using a colorimetric
enzymatic kit. *significantly different, p < 0.05. Values are mean ± SD, n = 3.
One of the additional mechanisms for increased oxidative
damage under accumulation of NADH+2 is the formation of
H2O2 that promotes reactive oxygen species formation (Circu
and Aw, 2010). Intriguingly, the NADPH+2 to NADP
+ ratio
is decreased under hypoxia as we discussed above (Figure 2).
This may cause additional oxidative damage due to involvement
of NADPH+2 in enzymatic detoxification of reactive oxygen
species. However, because an active mitochondrial FA synthase
may use NADH+2 as a cofactor (Podack and Seubert, 1972;
Seubert and Podack, 1973; Hinsch and Seubert, 1975; Whereat
and Rabinowitz, 1975; Hinsch et al., 1976; Hiltunen et al.,
2010; Smith et al., 2012) and H2 is readily transferred from
NADH+2 to NADP
+ by transhydrogenases (Bizouarn et al., 2000;
Jackson et al., 2002), increased FA synthesis may not cause
but rather protect against oxidative damage; 3. Altered gene
expression and protein modifications through increased protein
acetylation. The NADH+2 /NAD
+ ratio modulates the activity of
the NAD-dependent deacetylase sirtuin Sirt1 (Lin et al., 2004)
that plays a central role in the regulation of thousands of
metabolic enzymes and transcription factors in the cytosol and
mitochondria (Hallows et al., 2006; Herranz and Serrano, 2010;
Wang et al., 2010; Zhao et al., 2010; Hirschey et al., 2011); 4.
Decreased rates of oxidation metabolic reactions including the
glycolytic pathway. Because over 700 oxidoreduction enzymes
use NAD+ or NADP+ as cofactors (Sun et al., 2012), the
reduced availability of oxidized NAD+ and NADP+ globally
effects cellular biochemical processes; 5. In addition, the altered
reduction potential further reduces ATP production (Pettit
et al., 1975), causing neuronal damage. Few mechanisms are
involved in the reduction of ATP production including allosteric
regulation and oxidized cofactor availability.
Because FA synthesis consumes H2 from two NADPH
+
2
per each acetyl-CoA incorporated into FA chain, H2 is readily
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transferred from NADH+2 to NADP
+ by transhydrogenases
(Bizouarn et al., 2000; Jackson et al., 2002), and an active
mitochondrial FA synthase may use NADH+2 as a cofactor
(Podack and Seubert, 1972; Seubert and Podack, 1973; Hinsch
and Seubert, 1975; Whereat and Rabinowitz, 1975; Hinsch et al.,
1976; Hiltunen et al., 2010; Smith et al., 2012), we hypothesized
that increased FA synthesis under hypoxia has a role in
maintaining cellular reduction potential. Importantly, under
hypoxia each acetyl-CoA produced from glucose also produces
two NADH+2 . One is produced during anaerobic glycolysis,
and another one during pyruvate oxidative decarboxylation.
Thus, activation of FA synthesis will stoichiometrically use all
NADH+2 produced in the anaerobic glycolysis and will prevent
hydrogen accumulation in the form of lactic acid. In addition,
it will support Glu oxidation also associated with NAD(P)H+2
formation (McKenna, 2007). Using a loss of function approach
through inhibition of FA synthesis at two different metabolic
reactions at not-cytotoxic levels, we demonstrated a dramatic
increase in NADH+2 /NAD
+ and NADPH+2 /NADP
+ ratios under
hypoxia compared to vehicle-treated hypoxic neuronal cells
(Figure 2).
FA synthesis inhibition also resulted in the increased lactic
acid levels, and caused a significant toxicity under hypoxia
but not normoxia (Figure 3). Because TOFA may alter a
number of different pathways, it is difficult to provide a
conclusive interpretation of the toxicity mechanism of fatty acid
inhibition under hypoxia. However, because reductive potential
was increased with both inhibitors under hypoxia, and increased
reductive potential is the cause but not a direct result of apoptosis
(Circu and Aw, 2010; Redza-Dutordoir and Averill-Bates, 2016),
we speculate that decreased consumption of reduced cofactors
in fatty acid synthesis pathway through inhibition may lead to
cellular death under hypoxia.
Together, these data strongly indicate that FA synthesis is
important for maintaining reduction potential and decreasing
lactic acid, in order to support cell survival under hypoxia. These
findings may help to identify a radically different approach to
attenuate hypoxia related pathophysiology in the nervous system
including stroke.
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